Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-043285
Filing Date
2025-05-14
Accepted
2025-05-14 16:04:34
Documents
81
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0241915-10q_pmgc.htm   iXBRL 10-Q 845816
2 CERTIFICATION ea024191501ex31-1_pmgc.htm EX-31.1 10962
3 CERTIFICATION ea024191501ex31-2_pmgc.htm EX-31.2 10846
4 CERTIFICATION ea024191501ex32-1_pmgc.htm EX-32.1 4352
5 CERTIFICATION ea024191501ex32-2_pmgc.htm EX-32.2 4359
  Complete submission text file 0001213900-25-043285.txt   6375300

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE elab-20250331.xsd EX-101.SCH 68816
7 XBRL CALCULATION FILE elab-20250331_cal.xml EX-101.CAL 52612
8 XBRL DEFINITION FILE elab-20250331_def.xml EX-101.DEF 324257
9 XBRL LABEL FILE elab-20250331_lab.xml EX-101.LAB 568010
10 XBRL PRESENTATION FILE elab-20250331_pre.xml EX-101.PRE 345566
84 EXTRACTED XBRL INSTANCE DOCUMENT ea0241915-10q_pmgc_htm.xml XML 737807
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41875 | Film No.: 25945231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)